Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
Brazil · Delayed Price · Currency is BRL 618.38
0.00 (0.00%)
At close: Feb 6, 2026
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 632.9 billion as of February 6, 2026. Its market cap has decreased by -5.57% in one year.
Market Cap
632.90B
Enterprise Value
579.79B
Revenue
62.48B
Ranking
n/a
PE Ratio
32.31
Stock Price
618.38
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 83.36M to 632.90B, an increase of 759,148.58%. That is a compound annual growth rate of 29.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 632.90B | -0.10% |
| Dec 31, 2025 | 633.56B | -1.22% |
| Dec 31, 2024 | 641.42B | 26.08% |
| Dec 29, 2023 | 508.76B | 29.82% |
| Dec 30, 2022 | 391.88B | 25.97% |
| Dec 31, 2021 | 311.09B | -2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.82B |
| Raia Drogasil | 45.90B |
| Hypera | 14.79B |
| Fleury | 9.18B |
| Odontoprev | 6.50B |
| Diagnósticos da América | 5.19B |
| Empreendimentos Pague Menos | 4.19B |
| Oncoclínicas do Brasil Serviços Médicos | 2.78B |